• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺转录因子1及细胞角蛋白1、5、10、14(34βE12)在肺基底样癌和大细胞神经内分泌癌中的表达

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

作者信息

Sturm N, Lantuéjoul S, Laverrière M H, Papotti M, Brichon P Y, Brambilla C, Brambilla E

机构信息

Laboratoire de Pathologie Cellulaire, Service de Chirurgie Thoracique, and Lung Cancer Research Group, INSERM 9924, Centre Hospitalo-Universitaire Albert Michallon, Grenoble, France.

出版信息

Hum Pathol. 2001 Sep;32(9):918-25. doi: 10.1053/hupa.2001.27110.

DOI:10.1053/hupa.2001.27110
PMID:11567220
Abstract

Basaloid carcinoma (BC) and large-cell neuroendocrine carcinoma (LCNEC) are 2 recently recognized variants of large-cell lung carcinomas that may overlap in their morphology, and are discriminated by expression of neuroendocrine markers in LCNEC. Because thyroid transcription factor 1 (TTF-1) is expressed in lung adenocarcinomas but not in squamous cell carcinomas (SCC), and 34betaE12 recognizes a set of high-molecular-weight cytokeratins characteristic of basal stem cells, we hypothesized that these 2 markers could help in distinguishing BC from LCNEC. Immunostaining for TTF-1 was detected in 40.9% of pure LCNEC but in no BC or basaloid variant of SCC. In contrast, immunoreactivity for 34betaE12 was shown in all BC and basaloid variant of SCC but in only 1 LCNEC. Bouin fixation was less efficient than formalin in the immunodetection of both markers for its well-known deleterious effect on antigen preservation. Specificity of TTF-1 for LCNEC (100%) and that of 34betaE12 for BC (98.3%) exceeded that of NE markers for distinction of these 2 entities. These data show that TTF-1 and 34betaE12, in association with specific neuroendocrine markers, represent a useful panel of antibodies in differentiating carcinomas presenting with a solid pattern, palisading, or pseudorosettes, the expression of TTF-1 excluding the diagnosis of BC, and staining with 34betaE12 excluding pure LCNEC.

摘要

基底样癌(BC)和大细胞神经内分泌癌(LCNEC)是最近才被认识的大细胞肺癌的两种变体,它们在形态上可能重叠,可通过LCNEC中神经内分泌标志物的表达来区分。由于甲状腺转录因子1(TTF-1)在肺腺癌中表达而在鳞状细胞癌(SCC)中不表达,且34βE12识别一组基底干细胞特有的高分子量细胞角蛋白,我们推测这两种标志物有助于区分BC和LCNEC。在40.9%的纯LCNEC中检测到TTF-1免疫染色,但在BC或SCC的基底样变体中均未检测到。相反,在所有BC和SCC的基底样变体中均显示34βE12免疫反应性,但仅在1例LCNEC中显示。由于Bouin固定对抗原保存有众所周知的有害作用,在两种标志物的免疫检测中其效率低于福尔马林固定。TTF-1对LCNEC的特异性(100%)和34βE12对BC的特异性(98.3%)超过了用于区分这两种实体的神经内分泌标志物的特异性。这些数据表明,TTF-1和34βE12与特定的神经内分泌标志物联合,在鉴别呈现实性模式、栅栏状或假菊形团的癌中是一组有用的抗体,TTF-1的表达可排除BC的诊断,而34βE12染色可排除纯LCNEC。

相似文献

1
Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.甲状腺转录因子1及细胞角蛋白1、5、10、14(34βE12)在肺基底样癌和大细胞神经内分泌癌中的表达
Hum Pathol. 2001 Sep;32(9):918-25. doi: 10.1053/hupa.2001.27110.
2
TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.TTF-1、细胞角蛋白7、34βE12和CD56/NCAM免疫染色在肺大细胞癌亚分类中的应用
Am J Clin Pathol. 2004 Dec;122(6):884-93.
3
Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.与小细胞肺癌相比,肺大细胞神经内分泌癌中细胞角蛋白 7、8、18、19 的高表达更为显著。
Pathol Int. 2010 Feb;60(2):71-7. doi: 10.1111/j.1440-1827.2009.02487.x.
4
Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.具有基底样特征的肺癌的细胞学、组织学和免疫组化结果。
Diagn Cytopathol. 2011 Feb;39(2):92-100. doi: 10.1002/dc.21335.
5
Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.上皮和神经内分泌抗体的免疫反应性在肺癌的鉴别诊断中很有用。
Hum Pathol. 2000 Aug;31(8):980-7. doi: 10.1053/hupa.2000.9076.
6
Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology.具有高级别基底样或神经内分泌形态的肺肿瘤细胞病理学诊断问题。
Diagn Cytopathol. 2011 Mar;39(3):159-67. doi: 10.1002/dc.21351.
7
High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.肺高级别神经内分泌癌:大细胞神经内分泌癌与小细胞肺癌的临床病理对照研究
Pathol Int. 2009 Aug;59(8):522-9. doi: 10.1111/j.1440-1827.2009.02402.x.
8
Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.高分子量细胞角蛋白而非p63在头颈部神经内分泌癌和基底样癌鉴别诊断中的应用
Hum Pathol. 2008 Apr;39(4):591-8. doi: 10.1016/j.humpath.2007.08.019. Epub 2008 Mar 4.
9
Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.腮腺原发性大细胞神经内分泌癌:两例病例的免疫组织化学和分子分析
Mod Pathol. 2000 May;13(5):554-61. doi: 10.1038/modpathol.3880096.
10
Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.细胞角蛋白7和20以及甲状腺转录因子1有助于区分肺类癌、胃肠道类癌和胰腺内分泌肿瘤。
Hum Pathol. 2001 Oct;32(10):1087-93. doi: 10.1053/hupa.2001.28245.

引用本文的文献

1
Comparison of CT findings between basaloid squamous cell carcinoma and non-basaloid squamous cell carcinoma of the lung.肺基底样鳞状细胞癌与非基底样鳞状细胞癌的CT表现比较。
Sci Rep. 2024 Dec 28;14(1):31371. doi: 10.1038/s41598-024-82896-5.
2
Small cell lung cancer and neuroendocrine tumours.小细胞肺癌和神经内分泌肿瘤。
Breathe (Sheff). 2024 Nov 12;20(3):240004. doi: 10.1183/20734735.0004-2024. eCollection 2024 Oct.
3
Perioperative serplulimab‑based chemoimmunotherapy in stage IV large cell neuroendocrine carcinoma of the lung: A case report.
围手术期基于斯鲁利单抗的化疗免疫疗法治疗IV期肺大细胞神经内分泌癌:一例报告
Oncol Lett. 2024 Sep 12;28(5):547. doi: 10.3892/ol.2024.14680. eCollection 2024 Nov.
4
Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevance.非小细胞肺癌向小细胞肺癌的转化:生物学机制及临床意义。
Chin Med J Pulm Crit Care Med. 2024 Feb 6;2(1):42-47. doi: 10.1016/j.pccm.2023.10.005. eCollection 2024 Mar.
5
Pulmonary Large Cell Neuroendocrine Carcinoma.肺大细胞神经内分泌癌。
Pathol Oncol Res. 2022 Oct 11;28:1610730. doi: 10.3389/pore.2022.1610730. eCollection 2022.
6
Morphologic and molecular classification of lung neuroendocrine neoplasms.肺神经内分泌肿瘤的形态学和分子分类。
Virchows Arch. 2021 Jan;478(1):5-19. doi: 10.1007/s00428-020-03015-z. Epub 2021 Jan 21.
7
Small-cell lung cancer.小细胞肺癌。
Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0.
8
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.大细胞神经内分泌癌和小细胞肺癌的新分子分类及其潜在治疗意义。
Transl Lung Cancer Res. 2020 Oct;9(5):2233-2244. doi: 10.21037/tlcr-20-269.
9
The Diagnostic Value of TTF-1, P63, HMWK, CK7, and CD56 Immunostaining in the Classification of Lung Carcinoma.TTF-1、P63、高分子量角蛋白(HMWK)、CK7和CD56免疫染色在肺癌分类中的诊断价值
Iran J Pathol. 2017 Summer;12(3):195-201. Epub 2017 Jul 1.
10
Classification of pulmonary neuroendocrine tumors: new insights.肺神经内分泌肿瘤的分类:新见解
Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04.